Ottawa, June 24, 2024 (GLOBE NEWSWIRE) -- The global tendonitis treatment market size is predicted to increase from USD 214.26 billion in 2023 to approximately USD 298.14 billion by 2032. This market is registering a CAGR of 3.6% from 2024 to 2032.
Download a sample version of this report (regional analysis, segmental analysis and future growth in detail) @ Get Sample of Tendonitis Treatment Market Report Here (2024 - 2032)
Key takeaways
- North America led the market with the largest share in 2023.
- By type, tennis elbow segment dominated the market in 2023
- By treatment, physical therapy segment dominated the market in 2023
The tendonitis treatment market has been experiencing significant growth, driven by several key factors. Tendonitis, an inflammation of the tendons, is a common condition that affects a wide range of individuals, from athletes to those engaged in repetitive work tasks. This condition can cause pain and limit mobility, making effective treatment options essential.
Tendonitis treatment market at a glance
Tendinitis, also refers to tendonitis, is a condition where a tendon becomes inflamed or irritated, usually due to overuse or injury. Tendons are the thick cords that attach muscles to the bones, and when they become swollen, it can cause pain and limit movement. The tendinitis treatment market focuses on providing various methods and products to help manage and heal this painful condition.
One of the primary drivers of the tendonitis treatment market is the increasing participation in sports and physical activities. As more people engage in sports, the incident of tendonitis- related injuries rises, leading to a higher demand for treatment options. Athletes are prone to developing tendonitis due to the repetitive motions and high- impact activities inherent in many sports. This has resulted in a growing market for therapies and interventions that can quickly and effectively address these injuries.
In addition to sports-related injuries, the aging population is another significant factor contributing to market growth. As people age, their tendons become less flexible and more susceptible to injury. This demographic shift has led to a higher prevalence of tendonitis among older adults, further driving the need for effective treatment solutions.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Top companies in the tendonitis treatment market:
- Arthrex
- Zimmer Biomet
- Stryker Corporation
- Johnson & Johnson
- Smith & Nephew
- Pfizer Inc.
- Merck & Co., Inc.
- Novartis AG
- Abbott Laboratories
Growing incidence of tendonitis spurs market expansion
Tendonitis is a widespread condition that affects individuals of all ages, though it is particularly common among athletes and older adults. The growing popularity of sports and recreational activities, combined with an aging population, has led to an increase in tendonitis cases. This condition occurs when tendons, the tissues that connects to muscles bones inflamed. This inflammation often causes pain and limits mobility, necessitating effective treatment options.
Every year around 70,000 Americans are unable to work due to tendonitis, according to the Bureau of Labor Statistics. This number is increasing, highlighting the urgent need for better treatment solutions. The affected areas frequently include the shoulders, elbows, wrists, knees and heels, with common types of tendonitis being tennis elbow, golfer’s elbow, pitcher’s shoulder, swimmer’s shoulder, mothers wrist, jumpers knee and Achilles tendons.
The general public is experiencing an increase in tendonitis cases, estimated at approximately 5 to 10 cases per 100,000 individuals. This trend is expected to drive market demand for treatment options.
Customize this study suitable to your needs and requirements @ Get Customization in Tendonitis Treatment Market Report Here
Sedentary lifestyle across the globe to create a significant driver
The rise of sedentary lifestyle is becoming a significant driver for the tendonitis treatment market. This lack of physical activity can weaken tendons over time, making them more prone to injury and inflammation. Office workers and individuals with screen- based hobbies are particularly at risk, as their daily routines often involve minimal movement and repetitive strain on specific tendons.
For example, many office workers spend hours typing on keyboards and using mice, which can lead to conditions like “tennis elbow” or “golfer’s elbow”, despite not engaging in these sports.
Lack of Public Awareness to Create a Restraint
While tendonitis is a common condition, many people are not aware of its signs and symptoms. This lack of awareness can lead to delayed diagnosis and treatment, potentially worsening the condition. Tendonitis, an inflammation or irritation of a tendon, often presents with symptoms such as pain, swelling, and limited movement in the affected area. However, because these symptoms can be mistaken for other issues like muscle strain or arthritis, people often ignore them, hoping they will resolve on their own.
- For instance, a person experiencing persistent pain in their elbow after a game of tennis might dismiss it as a temporary discomfort, not realizing it could be tennis elbow, a form of tendonitis.
This delay in seeking medical attention can exacerbate the condition, making treatment more complicated and prolonged. Early intervention typically involves rest, physical therapy, and anti-inflammatory medications, which are often sufficient to resolve the issue. However, when tendonitis is not addressed promptly, it can lead to chronic pain and may require more intensive treatments such as corticosteroid injections or even surgery.
Minimally Invasive Surgical Techniques to Open Opportunities
The development of new minimally invasive surgical techniques presents a significant opportunity for the tendonitis treatment market. These advanced procedures allow for faster recovery times, less tissue damage, and reduced pain compared to traditional surgeries, making surgical intervention a more appealing option for patients when necessary.
Minimally invasive surgery involves smaller incisions, which leads to less disruption of the surrounding tissues. This results in a quicker healing process, less postoperative pain, and a lower risk of complications such as infections. For instance, arthroscopic surgery, commonly used to treat tendonitis in joints like the shoulder or knee, involves inserting a tiny camera and surgical instruments through small incisions. This allows surgeons to precisely address the damaged tendon while minimizing trauma to the surrounding area.
North America to sustain as a leader in the market
North America leads the tendonitis treatment market, driven by advanced healthcare infrastructure and a high prevalence of sports-related injuries. Cities like New York, Los Angeles, and Toronto are hubs for specialized tendonitis treatments, thanks to numerous healthcare facilities offering cutting-edge therapies. The region's market growth is also fueled by the increasing affordability of medical procedures and the presence of both established and emerging local manufacturers. These companies are continuously innovating, resulting in more personalized and cost-effective treatment options for patients.
Recent advancements in North America include the introduction of sophisticated imaging technologies and minimally invasive surgical procedures, which have improved the accuracy of tendonitis diagnosis and treatment.
Asia Pacific on to grow at a rapid rate
The Asia-Pacific region presents a diverse and rapidly growing tendonitis treatment market. Countries across the region, including smaller towns and rural areas, are seeing an increase in the availability of treatment options. This growth is primarily driven by better access to healthcare services and a rising awareness of tendonitis among the general population.
Local companies in Asia-Pacific are collaborating with major global players to develop innovative and effective treatments for tendonitis. These partnerships enhance the availability and affordability of treatments, ensuring that more patients can receive the care they need. The increasing number of people diagnosed and treated for tendonitis in the region is a testament to these efforts.
- In recent years, the Asia-Pacific region has seen significant developments in tendonitis treatments. For example, in 2021, Stryker introduced the Citrelock Tendon Fixation Device System, a new tool that repairs damaged tendons without causing further harm.
India, as a part of the Asia-Pacific region, is experiencing notable growth in the tendonitis treatment market. The increasing participation in sports and fitness activities has led to a higher incidence of tendon-related injuries, driving demand for effective treatments. Additionally, the aging population in India is more susceptible to tendonitis, further fueling market growth.
Recent developments in India's healthcare sector have significantly improved the diagnosis and treatment of tendonitis. The introduction of advanced medical technologies and therapies has made treatment more effective and accessible. For instance, the launch of new physical therapy techniques and minimally invasive surgical procedures has provided patients with better options for managing and recovering from tendonitis.
By type, the tennis elbow segment to lead the market
Tennis elbow is the most common type of tendonitis, characterized by pain and tenderness on the outer part of the elbow. This condition often affects people who perform repetitive arm and wrist movements, not just tennis players. Its prevalence makes it a significant segment in the tendonitis treatment market, with numerous therapies and interventions developed specifically to address it.
By treatment, the physical therapy segment to sustain as a leader
Physical therapy stands out as the leading treatment for tendonitis. It involves exercises and techniques designed to strengthen the muscles around the affected tendon, improve flexibility, and reduce pain. This approach is highly effective in managing chronic tendonitis and preventing recurrence, making it the preferred choice for many patients and healthcare providers.
Major Breakthroughs in the Tendonitis Treatment Market:
- In 2024, Arthrex, a leading medical device company, announced the launch of its new JetStream Micro W Arthroscopy System in the US. This minimally invasive system allows for improved visualization and potentially faster recovery times during shoulder arthroscopy for rotator cuff tendonitis repair.
- In 2024, A study published in the American Journal of Sports Medicine found that the use of photobiomodulation therapy, a light-based treatment, combined with physical therapy showed promising results in reducing pain and improving function in patients with chronic Achilles tendonitis.
- In 2024, The American Academy of Orthopaedic Surgeons (AAOS) released updated clinical guidelines for the treatment of Achilles tendonitis. These guidelines emphasize the importance of non-surgical treatment options like physical therapy and patient education in the initial stages of management.
Browse More Insights of Towards Healthcare:
- The global digital health market is was estimated at USD 262.63 billion in 2022 to reach around USD 939.54 billion by 2032, expanding at a 13.1% of CAGR between 2023 and 2032.
- The global health and wellness market is to grow from USD 5.24 trillion in 2022 to hit an estimated USD 8.94 trillion by 2032, at an expanding 5.46% CAGR between 2023 and 2032.
- The global hospital services market was valued at USD 9.29 trillion in 2022, projected to reach USD 21.27 trillion by 2032, growing at a CAGR of 9.15% from 2023 to 2032.
- The global central lab market surpassed USD 3.1 billion in 2022 and is expected to reach USD 5.4 billion by 2032, expanding at a 5.71% CAGR from 2023 to 2032.
- The global biosimilar market size to grow from USD 25,125.36 million in 2022 to hit around USD 1,26,019.67 million by 2032, at a staggering CAGR of 17.6% between 2023 and 2032.
- The global acne treatment market was estimated at USD 9,6615.6 million in 2022 to reach around USD 15,183.2 million by 2032, growing at 4.8% of CAGR from 2023 to 2032.
- The global newborn imaging system market size was projected at USD 277.64 million in 2022 to soar around USD 441.42 million by 2032, growing at a CAGR of 4.6% between 2023 and 2032.
- The global biotechnology market size to grow from USD 1,224.31 billion in 2022 to reach USD 3,995.22 billion by 2032, expanding at a CAGR of 12.5% between 2023 and 2032.
- The global brain computer interface market size was valued at USD 2,130 million in 2022 and is estimated USD 9,445.1 million by 2032, growing at a healthy 16.7% of CAGR from 2023 to 2032.
- The global single-use bioprocessing market revenue surpassed USD 20.96 billion in 2022 to reach around USD 84.14 billion by 2032, at a double digit CAGR of 15.46% from 2023 to 2032.
Tendonitis Treatment Market Segment
By Type
- Tennis Elbow
- Golfer’s Elbow
- Pitcher’s Shoulder
- Swimmer’s Shoulder
- Runner’s Knee
By Treatment
- Therapy
- Hot and Cold Therapy
- Physical Therapy
- Shock Wave Therapy
- Medications
- Pain Relievers
- Corticosteroid Injections
- Other Medications
- Surgery
By Geography
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- South America
Acquire our comprehensive analysis today @ https://www.towardshealthcare.com/price/5135
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Gain access to the latest insights and statistics in the healthcare industry by subscribing to our Annual Membership. Stay updated on healthcare industry segmentation with detailed reports, market trends, and expert analysis tailored to your needs. Stay ahead of the curve with valuable resources and strategic recommendations. Join today to unlock a wealth of knowledge and opportunities in the dynamic world of healthcare: Get a Subscription
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.
Web: https://www.precedenceresearch.com
Browse our Brand-New Journals:
https://www.towardspackaging.com
https://www.towardsautomotive.com
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
Get Our Freshly Printed Chronicle: https://www.healthcarewebwire.com
